Cargando…

Correction: RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin

Detalles Bibliográficos
Autores principales:	Medina, Marisa W., Theusch, Elizabeth, Naidoo, Devesh, Bauzon, Frederick, Stevens, Kristen, Mangravite, Lara M., Kuang, Yu-Lin, Krauss, Ronald M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580222/ http://dx.doi.org/10.1371/annotation/1c64490e-a511-4843-8061-8e7312c69568

Ejemplares similares

RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2012)

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
por: Kim, Kyungpil, et al.
Publicado: (2014)

Participant-derived cell line transcriptomic analyses and mouse studies reveal a role for ZNF335 in plasma cholesterol statin response
por: Theusch, Elizabeth, et al.
Publicado: (2023)

SUGP1 is a novel regulator of cholesterol metabolism
por: Kim, Mee J., et al.
Publicado: (2016)

Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines
por: Theusch, Elizabeth, et al.
Publicado: (2020)

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy
por: Mangravite, Lara M., et al.
Publicado: (2013)

Coordinately Regulated Alternative Splicing of Genes Involved in Cholesterol Biosynthesis and Uptake
por: Medina, Marisa Wong, et al.
Publicado: (2011)

Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
por: Barber, Mathew J., et al.
Publicado: (2010)

Racial Differences in the Cholesterol-Lowering Effect of Statin
por: Naito, Ryo, et al.
Publicado: (2017)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Erratum: Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner
por: Theusch, E, et al.
Publicado: (2016)

Statin-induced expression change of INSIG1 in lymphoblastoid cell lines correlates with plasma triglyceride statin response in a sex-specific manner
por: Theusch, E, et al.
Publicado: (2017)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
por: Choi, Young Hwan, et al.
Publicado: (2014)

Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
por: Smit, Roelof AJ, et al.
Publicado: (2019)

ZNF542P is a pseudogene associated with LDL response to simvastatin treatment
por: Kim, Kyungpil, et al.
Publicado: (2018)

Correction: The Flavonoid Isoquercitrin Promotes Neurite Elongation by Reducing RhoA Activity
por: Palazzolo, Gemma, et al.
Publicado: (2012)

Correction to: Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
Publicado: (2023)

Statins suppress cell-to-cell propagation of α-synuclein by lowering cholesterol
por: Min, Joo-Ok, et al.
Publicado: (2023)

Implications of lower risk thresholds for statin treatment in primary prevention: Analysis of CPRD and simulation modelling of annual cholesterol monitoring
por: McFadden, Emily, et al.
Publicado: (2015)

Correction for Plakophilin 2 Couples Actomyosin Remodeling to Desmosomal Plaque Assembly via RhoA
Publicado: (2010)

Cholesterol lowering for secondary prevention: What statin dose should we use?
por: Josan, Kiranbir, et al.
Publicado: (2007)

Astragalus Polysaccharides Lowers Plasma Cholesterol through Mechanisms Distinct from Statins
por: Cheng, Yunjiu, et al.
Publicado: (2011)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Development and application of an algorithm for statin-induced myopathy based on electronic health record-derived structured elements
por: Oni-Orisan, Akinyemi, et al.
Publicado: (2023)

A polymorphism in HLA-G modifies statin benefit in asthma
por: Naidoo, Devesh, et al.
Publicado: (2014)

Correction: Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy
por: Diamond, David M, et al.
Publicado: (2023)

Correction: Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA Pathway
Publicado: (2014)

Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men
por: Faghihnia, Nastaran, et al.
Publicado: (2012)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Correction: RhoA promotes osteoclastogenesis and regulates bone remodeling through mTOR-NFATc1 signaling
por: Wang, Jirong, et al.
Publicado: (2023)

Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Statins Lower Lipid Synthesis But Promote Secretion of Cholesterol-Enriched Extracellular Vesicles and Particles
por: Chen, Yundi, et al.
Publicado: (2022)

Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
por: Li, Josephine H., et al.
Publicado: (2014)

Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort
por: Haldar, Tanushree, et al.
Publicado: (2022)

Correction: Myosin phosphatase and RhoA-activated kinase modulate neurotransmitter release by regulating SNAP-25 of SNARE complex
por: Horváth, Dániel, et al.
Publicado: (2017)

Author Correction: The RhoA dependent anti-metastatic function of RKIP in breast cancer
por: Kalpana, Gardiyawasam, et al.
Publicado: (2023)

Correction: How Statins May Protect against Alzheimer Disease
Publicado: (2012)

Author Correction: Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous
por: Mysore, Yashavanthi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pgqp7pio9q8cgddljtkt8f2kmn